title: GRP78 knockdown does not affect cytotoxicity of cisplatin in ovarian cancer cells.
authors.forename: Maximilian
authors.initials: M
authors.lastname: Kullmann
authors.forename: Sandra
authors.initials: S
authors.lastname: Kotz
authors.forename: Malte
authors.initials: M
authors.lastname: Hellwig
authors.forename: Ganna V
authors.initials: GV
authors.lastname: Kalayda
authors.forename: Sabine
authors.initials: S
authors.lastname: Metzger
authors.forename: Ulrich
authors.initials: U
authors.lastname: Jaehde
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D002945:Cisplatin / Q000494:pharmacology*; D019008:Drug Resistance, Neoplasm; D000091342:Endoplasmic Reticulum Chaperone BiP; D005260:Female; D006360:Heat-Shock Proteins / Q000502:physiology*; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D000091342:Endoplasmic Reticulum Chaperone BiP; C000717247:HSPA5 protein, human; D006360:Heat-Shock Proteins; D002945:Cisplatin